Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
07/2012
07/18/2012CN102584949A Pc-C polypeptide inhibiting aspergillus fumigatus from adhering to cornea
07/18/2012CN102584948A Polypeptide Pm8 capable of resisting oral cariogenic bacteria and preparation method thereof
07/18/2012CN102584947A Antibodies directed against hepatitis c virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions
07/18/2012CN102584946A Cam binding peptide and application thereof
07/18/2012CN102584945A Preparation method for ganirelix acetate
07/18/2012CN102584944A Preparation method of eptifibatide acetate
07/18/2012CN102584943A Vascular smooth muscle L type calcium ion channel immunogenic peptide and application thereof
07/18/2012CN102584942A Linear neutralizing epitope polypeptide of fowl reticuloendotheliosis virus gp90 protein and application thereof
07/18/2012CN102580609A Surfactant and preparation method thereof
07/18/2012CN101863958B Induction of the mitochondrial permeability transition
07/18/2012CN101724024B Polypeptide combined with immune antibody and application thereof
07/18/2012CN101501062B Novel biologically active peptides and their new uses
07/18/2012CN101189252B Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
07/17/2012US8222392 Kit for detection of telomerase reverse transcriptase nucleic acids
07/17/2012US8222216 Mesenchymal cell proliferation promoter and skeletal system biomaterial
07/17/2012US8222215 Methods for the use of inhibitors of antigen presentation by MHC class II molecules
07/17/2012US8222204 Influenza inhibiting compositions and methods
07/17/2012US8222202 Use of peptidic vasopressin receptor agonists
07/17/2012US8222201 Crystalline form of linaclotide
07/17/2012CA2718348C Orally administered peptides to ameliorate atherosclerosis
07/17/2012CA2501089C 4-methylhexanoic kahalaide f compound
07/17/2012CA2277486C Synthetic antibiotics
07/12/2012WO2012093293A1 Process for preparation of caspofungin acetate and intermediates
07/12/2012WO2011163228A3 Phage-gnrh constructs, their mimics, antigenic compositions, and sequences for immunocontraception of animals and other applications
07/12/2012WO2011116245A3 Methods of treating inflammation
07/12/2012US20120178904 Peptide analogs that are potent and selective for human neurotensin receptor subtype 2
07/12/2012US20120178903 Methods and Compositions Related to Adenoassociated Virus-Phage Particles
07/12/2012US20120178901 Nucleic acids encoding peptides for treating wounds, anti-angiogenic compounds and uses thereof
07/12/2012US20120178900 Chromatographic processes and purified compounds thereof
07/12/2012US20120178701 Melanocortin Receptor-Specific Peptides
07/12/2012US20120178700 Peptidomimetic macrocycles
07/12/2012US20120178694 Modified Compstatin With Peptide Backbone And C-Terminal Modifications
07/12/2012US20120178688 Therapeutic agents for reducing parathyroid hormone levels
07/12/2012US20120178649 Methods of constructing and screening diverse expression libraries
07/12/2012US20120178145 Virus scaffold for self-assembled, flexible and light lithium battery
07/12/2012US20120178102 Characterization of granulocytic ehrlichia and methods of use
07/12/2012US20120177715 Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity
07/12/2012US20120177675 Chimaeric Protein
07/12/2012US20120177673 Immunity-inducing agent
07/12/2012US20120177672 Therapeutic peptides, polypeptides and nucleic acid sequences
07/12/2012US20120177669 Phosphopeptides as melanoma vaccines
07/12/2012US20120177571 Pancreatic endocrine cell indicating agent and utilization of same
07/12/2012US20120177568 Novel meditopes and related meditope-monoclonal antibody delivery systems, synthesis and therapeutic uses thereof
07/12/2012CA2826086A1 Process for preparation of caspofungin acetate and intermediates
07/11/2012EP2474560A1 Method for producing 11-sugar sialyloligosaccharide-peptide
07/11/2012EP2474553A2 Compounds for diagnosing apoptosis
07/11/2012EP2473518A2 Stabilized melanocortin ligands
07/11/2012EP2473517A1 Transglutaminase-activating peptide, and cosmetic or pharmaceutical composition containing same
07/11/2012EP1745065B1 Antimicrobial polypeptides
07/11/2012EP1513544B1 Retrocyclins: antiviral and antimicrobial peptides
07/11/2012EP1300416B1 Memory-enhancing peptides and the use thereof
07/11/2012CN1966520B Peptides and compounds that bind to a receptor
07/11/2012CN102574894A Stabilized melanocortin ligands
07/11/2012CN102574893A Novel antipathogenic peptides
07/11/2012CN102573894A 疫苗 Vaccine
07/11/2012CN102565416A Application of apolipoprotein Al as diabetes mellitus marker
07/11/2012CN102565006A Method for detecting interaction between membrane channel protein and targeted medicine and application of method
07/11/2012CN102558346A Monoclonal antibody anti-phiX174 phage splitting protein E, hybridoma cell strain producing antibody and epitope thereof
07/11/2012CN102558329A Group of specific polypeptides and application thereof in preparing reagents for early diagnosis of lung cancer
07/11/2012CN102558307A Octapeptin as well as preparation and application thereof
07/11/2012CN102558306A Antigen epitope for preventing and treating trichinosis, composition thereof and application thereof
07/11/2012CN102558305A Direct thrombin inhibitor polypeptide hydrated salt and synthetic method thereof
07/11/2012CN102558304A Self-assembling peptide, and application of self-assembling peptide to promoting tumor cell to form multicellular spheroid
07/11/2012CN102558303A Natural antioxidant peptide Tiannanin-C1, and preparation method and application thereof
07/11/2012CN102558302A Method for separating and purifying pristinamycin
07/11/2012CN102558301A Functional precision structure drug modifier-thymopetidum acetyl methyl ester conjugate (FPSDM-TP5) and preparation method thereof
07/11/2012CN102558300A Polypeptides capable of antagonizing corticotropin-releasing factor receptors 1 and application of polypeptides
07/11/2012CN102558270A 20(S) and 20(R)-dammarane-3beta,12beta,20,25-tetrol derivative and preparation method and application thereof
07/11/2012CN102552929A Method for enhancing targeting selectivity of administration system by modifying cell penetrating peptide
07/11/2012CN102552926A Osteosarcoma chemotherapeutics carrier and obtaining method thereof
07/11/2012CN101851274B Polypeptides for suppressing invasion of hepatitis C virus
07/10/2012US8217158 Immunotoxin fusion proteins and means for expression thereof
07/10/2012US8217138 Anti-inflammatory compounds and uses thereof
07/10/2012US8217137 Fullerene-based amino acids
07/10/2012US8217048 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
07/10/2012US8217012 Peptides for targeting apoptotic cells and uses thereof
07/10/2012US8217011 Peptides, compositions and uses thereof
07/10/2012US8216999 HCV NS3 protease inhibitors
07/10/2012CA2567797C Peptidic vasopressin receptor agonists
07/10/2012CA2510893C Binding agents which inhibit myostatin
07/10/2012CA2481369C Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
07/10/2012CA2439101C New medical uses of intercellular communication facilitating compounds
07/05/2012WO2012089103A1 Method for separating and purifying cyclohexapeptide compound and salt thereof
07/05/2012WO2012037498A3 Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo
07/05/2012US20120172318 PEPTIDES AND PEPTIDOMIMETICS USEFUL FOR INHIBITING THE ACTIVITY OF PROSTAGLANDIN F2alpha RECEPTOR
07/05/2012US20120172315 Peptides Used for Treating Cancers and, in Particular, Chronic Lymphoid Leukaemia
07/05/2012US20120172309 Transglutaminase-activating peptide and cosmetic or pharmaceutial composition containing same
07/05/2012US20120172308 Oligopeptides And Their Use In Cosmetics
07/05/2012US20120172293 Peptide and use thereof
07/05/2012US20120172287 Polypeptide Having Antibacterial Activity and Angiogenesis-Inducing Activity and Wound-Healing Drug Containing Said Polypeptide
07/05/2012US20120172285 Methods and compositions for specific modulation of mcl-1
07/05/2012US20120172284 Isozyme-specific antagonists of protein kinase c
07/05/2012US20120171710 Method for Grass Species Identification
07/05/2012US20120171247 Novel proteins within the type e botulinum neurotoxin complex
07/05/2012US20120171227 Pro-drug complexes and related methods of use
07/05/2012US20120171210 Methods and compositions for inhibiting c-met dimerization and activation
07/04/2012EP2472259A1 Specific molecules clinging to a lure
07/04/2012EP2471806A2 Cyclosporine derivates
07/04/2012EP2470650A1 Breast cancer related gene c12orf32
07/04/2012EP2470555A1 Method for purification of colistin and purified colistin components
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 423